Rela Hospital sets new global benchmark in Liver Transplant patient survival rate

Tuesday, February 2, 2021

Rela Hospital sets new global benchmark in Liver Transplant patient survival rate


RELA HOSPITAL SETS NEW GLOBAL BENCHMARK IN LIVER TRANSPLANT PATIENT SURVIVAL RATE

Worldwide the patient survival rate averages at 90% while Rela Hospital achieved a 99.2% patient survival rate. 

Chennai, February 2nd, 2021: Rela Hospital, a Multi-Speciality Quaternary Care Hospital at Chromepet, Chennai,has accomplished a truly remarkable global milestone of achieving 99.2% patient survival rate from the liver transplant surgeries performed since beginning of COVID pandemic.Recognized as having one of the world’s largest dedicated liver intensive care unit. Rela Hospital spearheads clinical innovations in paediatric and adult liver transplantation. The surgical outcomes at 99.2% is a testament to its preeminent position. According to National centre for Biotechnology information (NCBI Report), India records close to 1000 of liver transplants each year with survival rate of less than 90%. Since the beginning of pandemic, over 120 liver transplantations were performed at Rela Hospital, with a remarkable 99.2% success ratio. This phenomenal success is the outcome of pioneering work done by the team of highly renowned surgeons and physicians, liver specific anaesthetist, intensivist, nursing and support staff coupled with cutting edge technology such as robotics and laparoscopy surgery for donors.

Professor Mohamed Rela, Chairman -Rela Hospital, Said “We are an outlier in the right direction and we are proud of these results.Globally, the survival rates for liver transplantation averages around 90%, however our survival is much higher compared to global standard.This improved survival is a boon for our patients receiving specialized care from a team committed towards delivering top-notch treatment for Liver failure.”

In the past there has been scepticism and worry about outcome after liver transplantation by both patients and referring doctors. However the survival of liver transplantation has improved over the years. 90% perioperative survival is now recognised internationally as a benchmark for high quality liver transplant programs.Rela Hospital’s current patient survival rate of 99.2% I feel is a significant achievement.

“Our liver program continues to gain strength and has grown tremendously year after year. Patient access, innovative treatments and a proactive inter disciplinary care model for complex cases are what we have successfully built. Our outstanding liver transplant patient outcomes are a direct reflection of the tireless high quality of care provided to our patients by the entire team,” said Dr. Ilankumaran, CEO of Rela Hospitals.


Print


The Hindu
The New Indian Express
Deccan Chronicle

 

Dinamani
Dina Seithi
Sakshi

 

Andhra Jyothi
Aathm Hindu
Agami

 

Dabang Duniya
Daily News
Dainik Bhaskar

 

Dainik Poorvoday
Disha New Times
Global Bharath

 

Hindi Milaap
IndianEra
Kahi Ankahi

 

Kesari
Prathidhin Rajdhani
Punjab Kesari

 

Punjab Times
Swadesh
Vikasith Bharath Samachaar

 

Vrath Mitra
Central Chronicle
The Hills Times

 

The Meghalaya Guardian
The North East Times
 

 

 

 

 

 

 

 

 

 

 

Prof. Mohamed Rela

MS, FRCS, DSc

Chairman & Director, Dr. Rela Institute & Medical Centre

Abdominal Trauma, HPB Surgery and Liver Transplantation, Intestinal Rehabilitation and Transplantation, Liver Transplantation, Pancreatic Transplantation

Dr. Ilankumaran Kaliamoorthy 

FRCA

Chief Executive Officer & Senior Consultant, Liver Anaesthesia & Intensive Care

Anaesthesia & ICU, Liver Anaesthesia and Intensive Care

To seek a quick appointment

Copyrights © 2021 Rela Institute & Medical Centre. All Rights Reserved.